The effect of growth conditions on the antibacterial activity of DU-6859a against Staphylococcus auerus, Escherichia coli, and Pseudomonas aeruginosa was compared with those of levofloxacin, sparfloxacin, and ciprofloxacin. This activity was not affected by different media, inoculum size or the addition of human serum, but was decreased under acidic conditions, in human urine, and in the presence of magnesium and ferrous ion, as were the other quinolones tested. Time-kill curve studies demonstrated the bactericidal action of DU-6859a against S. aureus, Streptococcus pneumoniae, E. coli, and P. aeruginosa. Morphological alteration of these bacteria after exposure to DU-6859a also demonstrated its bactericidal activity. The frequency of spontaneous resistance to DU-6859a was less than or equal to those of the reference drugs.
Introduction
DU-6859a, a novel quinolone antibacterial agent, has activity against a wide range of bacteria and is particularly effective against Gram-positive bacteria (Sato et al., 1992) . The activity of quinolones is known to be decreased under acidic conditions and in the presence of magnesium and aluminum ions (Smith, Eng & Cherubin, 1988; Smith, 1990; Canton et al., 1992) . Some antacids containing magnesium and aluminum ions have been reported to antagonize the actions of quinolones (Shiba et al., 1992; Jaehde et al., 1994) . The present study investigated the effect of growth conditions, including different media, inoculum size and medium pH, urine, and the addition of metal ions and human serum, on the activity of DU-6859a. We also studied the bactericidal activity of DU-6859a. The standard MIC method for determining antibacterial activity provides no information on initial killing kinetics. This study therefore included the killing curve method to obtain additional information on the antibacterial properties of DU-6859a in vitro, particularly with regard to its initial bactericidal activity against selected strains. The morphological study using electron microscopy also provides additional information on its bactericidal activity and mode of action.
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Materials and methods
Antibacterial agents
DU-6859a, levofloxacin, ciprofloxacin, and sparfloxacin were synthesized at the New Product Research Laboratories I, Daiichi Pharmaceutical Co., Ltd., Tokyo, Japan.
Organisms
Staphylococcus aureus FDA 209-P, methicillin-resistant S. aureus 900056 and 900477, Streptococcus pneumoniae 57664, Escherichia coli K.L-16, and Pseudomonas aeruginosa PAO1 were used.
Effect of growth conditions
The effects of variations in inoculum size and medium pH, as well as the addition of metal ions and human serum, on DU-6859a activity were performed in Mueller-Hinton agar (MHA; Difco Laboratories, Detroit, Mich.) by the dilution method (NCCLS, 1990) . When testing S. pneumoniae, MHA supplemented 5% horse blood was used. Calcium chloride, magnesium chloride, aluminum chloride, zinc chloride, manganese chloride, ferrous chloride, and ferric chloride were added to Mueller-Hinton agar at the final concentrations of 5 mM. One loopful (5 /iL) of an inoculum corresponding to about 10*cfu per spot was inoculated on drug-containing agar plates, which were then incubated for 18 h at 37°C. The MIC was defined as the lowest drug concentration which prevented visible growth of bacteria. The effect of the medium was determined by the agar dilution method with nutrient agar (NA; Eiken Co., Ltd., Tokyo, Japan), tryptone soy agar (TSA; Eiken), heart infusion agar (HIA; Eiken), brain-heart infusion agar (BHIA; Difco) and Mueller-Hinton agar. The effect of human urine was examined by the macro dilution tube method (NCCLS, 1990) using Mueller-Hinton broth (MHB; Difco) and 100% human urine (pH 5.9). Final inoculum size was 5 x 10'cfu/mL.
Determination of bactericidal activity
The organisms incubated in Mueller-Hinton broth for 18 h at 37°C were diluted with fresh broth to about 10 3 cfu/mL, and the diluted cultures were then incubated with agitation for 2 h at 37°C. After this preincubation, cultures were incubated in the absence of the indicated drug, or in its presence at levels equivalent to 1/4, 1/2, 1, 2, and 4 times the MIC and, at time intervals of 0, 1, 2, 4, and 6 h, samples were removed, serially diluted, and plated to determine the number of viable cells. The colonies were counted after 24 h incubation at 37°C.
Samples of transmission electron microscopy (TEM) and scanning electron microscopy (SEM) bacterial suspensions used in the above-mentioned experiment were fixed with 1.5% glutaraldehyde and centrifuged at 6000 rpm for 20 min. The resulting bacterial pellets were fixed with 1 % osmium tetroxide, and washed in the buffer of Kellenberger, Ryter & Sechaud (1958) , (pH 6.0). After that, for SEM, bacterial pellets were dehydrated in graded ethanols, resuspended in isoamyl acetate, dried at the critical point of carbon dioxide, and covered with platinum palladium. For TEM, bacterial pellets were embedded in 2% purified agar, and small blocks were cut; these were stained with 0.5% uranyl acetate buffer (pH 6.0) for 2 h, dehydrated for 30 min in graded ethanols, embedded in epoxy resin (Luft, 1961) , sectioned into slices about 70 nm thick, and then stained again with uranyl acetate and lead citrate (Reynolds, 1963) . Nuclear staining was also performed with E. coli and observed by TEM (Zusman, Inouye & Pardee, 1972) .
Frequency of spontaneous resistance
The test strains were precultured in MHB for 20 h at 37°C until a concentration of 10 9 cfu/mL was achieved. The bacterial suspension was plated onto MHA plates containing two or four times the MIC of each compound. For testing S. pneumoniae, MHB supplemented with 5% horse serum and MHA with 5% horse blood were used. After 48 h at 37°C, colonies were counted and the frequency of spontaneous resistance was calculated as the ratio of the number of colonies grown on drug-containing plates to that on drug-free plates.
Development of resistance
Quinolones were prepared as two-fold dilutions in Mueller-Hinton broth. S. aureus FDA 209-P, E. coli KL-16, and P. aeruginosa PAO1 were inoculated at 10 5 cfu/mL into a dilution series of each drug. After overnight incubation at 37°C, the broth with the highest concentration of the drug showing turbidity in each series was subcultured into a new dilution series of the same agent. This procedure was repeated for ten days. The resulting bacteria were tested for susceptibility to each of the drugs by the standard agar dilution method described above.
Results
Effect of growth conditions on antibacterial activity
The MIC values of DU-6859a against S. aureus FDA 209-P, E. coli KL-16, and P. aeruginosa PAO1 were closely similar in all of the five media, namely MuellerHinton, nutrient, heart infusion, brain-heart infusion, and tryptone soy agar (data not shown). Alteration of the pH of Mueller-Hinton agar between 6 and 8, addition of human serum at 10%, 25%, and 50% to the medium, and increase of the inoculum size from 10 3 to 10 7 cfu each had no significant effect on the activity of DU-6859a against any strain. However, activity of DU-6859a at pH 5.5 was between one-half and one-sixteenth of the activity at higher pH, as were the activities of the other drugs tested (Figure 1) . In human urine, the MIC values against three strains of DU-6859a, levofloxacin, ciprofloxacin, and sparfloxacin were 2-8, 4-16, 2-16, and 8-32 times higher than the values in MHB, respectively. It was found that, irrespective of the bacterial species tested, calcium chloride, aluminum chloride, manganese chloride, and ferric chloride did not significantly alter the MIC of DU-6859a (Table) . The MICs of all compounds tested in the presence of magnesium chloride were two to four times higher than the MICs without metal ions. Zinc chloride showed bactericidal activity against the test strains. Against P. aeruginosa, metal ions did not antagonize any drug, but ferrous salts antagonized all quinolones, and manganese chloride antagonized the activity of the three reference drugs against E. coli.
Bactericidal activity
Killing curve studies showed that DU-6859a had rapid bactericidal activity against S. aureus FDA 209-P, S. pneumoniae 57664, E. coli KL-16, and P. aeruginosa PAOI at concentrations greater than the MIC (Figure 2) . Levofloxacin, ciprofloxacin and sparfloxacin showed similar bactericidal activity against these three strains. Against methicillin-resistant S. aureus 900477, DU-6859a showed bactericidal activity at concentrations greater than twice the MIC. Sparfloxacin showed only a 100-fold decrease at the maximum at a concentration of 4 times the MIC. Examination of the ultrastructure of untreated 5. aureus FDA 209-P cells in Figure 3 showed normal cell walls and cytoplasm containing evenly dispersed ribosomes and nuclear material in untreated cells. The typical alterations of S. aureus cells exposed to DU-6859a were abnormal cell division and cell lysis. Normal S. pneumoniae cells had a thick capsule, so that the cell surface could not be observed. Abnormal cell division and cell lysis were observed as with S. aureus in treated cells (Figure 4 ). In the case of E. coli (Figure 5 ), DU-6859a induced filamentation, cytoplasmic shrinkage and lysis. The cells of P. aeruginosa PAO1 treated with DU-6859a appeared to be spheroplasts, blebs and lysed cells (Figure 6 ). Nuclear staining showed the direct effect of DU-6859a on DNA synthesis in E. coli (Figure 7) . Small nuclei dispersed in filamentous cells were apparent after exposure to the MIC of DU-6859a, and disappeared at 4 times the MIC. 
Frequency of spontaneous resistance
The frequency of spontaneous resistance of S. aureus FDA 209-P, S. pneumoniae 57664, E. coli KL-16, P. aeruginosa PAOl and the two strains of MRSA at twice the MIC of DU-6859a were 4.4x10-", <5.0 x 10" 8 , <1.9xlO 9 , 7.1 x IO"\ 2.7 x 10" 9 , and 4.2 x 10~\ respectively. Against sparfloxacin, a higher frequency of resistance was shown by the two strains of MRSA (1.4 x 10" 6 and 9.1 x 10~6) than to the other compounds. The frequency of S. pneumoniae resistance at twice the MIC of sparfloxacin and ciprofloxacin was higher than that of DU-6859a and levofloxacin. Except for the above cases, there were no particular differences in the frequency of resistance of the species used to the quinolones tested.
Development of resistance
Against resistant strains selected after ten serial exposures to DU-6859a, this agent showed MICs that were 4, 16, and 32 times those against the parent strain of S. aureus, E. coli, and P. aeruginosa, respectively (Figure 8 ). The initial MIC values determined by broth dilution were almost half of those determined by the agar dilution method. Against resistant strains selected using levofloxacin, ciprofloxacin and sparfloxacin, on the other hand, these agents showed MICs 4, 8, and 64 times those against the S. aureus parent strain, respectively. For E. coli and P. aeruginosa, the corresponding values ranged, respectively, from 16 to 64 times and from 32 to 128 times those against the parent strains.
Discussion
In the past few years, a large number of fluoroquinolones have been developed (Hooper & Wolfson, 1991) . There has been a concerted effort to synthesize new agents with improved activities, especially against Gram-positive bacteria. DU-6859a, a novel quinolone antibacterial agent, has activity against a wide range of bacteria, and is particularly effective against Gram-positive bacteria (Sato et al., 1992) . The effects of growth conditions on the antibacterial activity of DU-6859a were studied. The activity of DU-6859a decreased at a low pH and in human urine, and there was a decrease in activity in the presence of 5 mM ferrous ion. Smith reported the significant effect of 5 mM aluminum, ferrous, and ferric ions on the activity of quinolones (Smith, 1990) . In our results, aluminum and ferric ions did not affect the activity of quinolones. It was speculated that the difference of inoculum size was the main cause of the differences in the results: Smith inoculated 20 to 100 cfu/plate, while we used 10*cfu/plate. The influence of high concentrations (8.4 and 9.3 mM) of magnesium has been demonstrated (Hirschhorn & Neu, 1986; Canton et al., 1992) , and a similar result (decrease to between one-fourth and one-eighth) was observed at 5 mM.
Time-kill curve studies showed the rapid bactericidal action of DU-6859a, but the bactericidal activity of the drugs tested against methicillin-resistant S. aureus was the weakest among the strains tested, especially with sparfloxacin. The bactericidal activity of DU-6859a was similar to those of ciprofloxacin (Chalkley & Koornhof, 1985) and AM-1155 (Hosaka et al., 1992) . Morphological alterations of S. aureus, E. coli and P. aeruginosa exposed to DU-6859a were similar to the alterations of cells treated with ofloxacin, ciprofloxacin, and levofloxacin reported previously (Dougherty & Saukkonen, 1985; Elliott, Shelton & Greenwood, 1987; Tanaka, Otsuki & Nishino, 1992) . In E. coli and P. aeruginosa, the frequency of spontaneous mutants resistant to DU-6859a was similar to the frequency of resistance to levofloxacin, ciprofloxacin, and sparfloxacin. However, the frequency of the resistance mutation of S. aureus to DU-6859a was lower than those to ciprofloxacin and sparfloxacin. Furthermore, the development of resistance after consecutive exposure of S. aureus to quinolones demonstrated that the emergence of resistance to DU-6859a was slower than that to sparfloxacin. These findings suggest the effectiveness of DU-6859a against various bacterial infections.
